Martin S. Brown's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 1,000 Common Stock done at an average price of $5.2 . Disclosure was reported to the exchange on March 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharmaceuticals... | Martin S. Brown | Director | Grant, award, or other acquisition of securities at price $ 5.17 per share. | 17 Mar 2025 | 1,000 | 8,500 (0%) | 0% | 5.2 | 5,170 | Common Stock |
Cumberland Pharmaceuticals... | Martin S. Brown | Director | Grant, award, or other acquisition of securities at price $ 1.71 per share. | 25 Mar 2024 | 2,500 | 7,500 (0%) | 0% | 1.7 | 4,275 | Common Stock |
Cumberland Pharmaceuticals... | Martin S. Brown | Director | Grant, award, or other acquisition of securities at price $ 1.71 per share. | 25 Mar 2024 | 1,000 | 6,000 (0%) | 0% | 1.7 | 1,710 | Common Stock |
Cumberland Pharmaceuticals... | Martin S. Brown | Director | Grant, award, or other acquisition of securities at price $ 1.97 per share. | 24 Mar 2023 | 1,000 | 5,000 (0%) | 0% | 2.0 | 1,970 | Common Stock |